(Press-News.org) Raghu R. Chivukula, MD, PhD, a physician-investigator in the Departments of Medicine & Surgery and the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School, is the senior author of a paper published in Science, “Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.”
Q: How would you summarize your study for a lay audience?
Neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease, are devastating and incurable diseases. Although many neurodegenerative diseases are characterized by abnormal protein aggregation in the brain, a limited understanding of whether and how aggregated proteins cause brain cell dysfunction and death represents a major barrier to developing effective treatments.
Inspired by similar approaches in cardiovascular disease and cancer, we focused on rare genetic forms of neurodegeneration as a powerful way to uncover fundamental mechanisms tying protein aggregation to brain disease. Our work unexpectedly linked protein aggregation in genetic forms of neurodegeneration to disrupted processing of transfer RNAs (tRNAs), revealing an important mechanism that might be therapeutically targeted in these disorders.
Q: What question were you investigating?
We became interested in genetic forms of neurodegeneration caused by GGC trinucleotide repeat expansions (DNA sequence mutations caused by copying this 3-letter sequence too many times in a row). These mutations produce aggregation-prone proteins with long stretches of a single repeated amino acid (glycine). Interestingly, although these “polyglycine”-containing protein aggregates are detectable in many tissue and cell types of affected patients, GGC repeat expansion disorders seem to cause disease only in the central nervous system.
We wanted to understand exactly what polyglycine aggregates do to cells and why they are selectively toxic to cells in the brain.
Q: What methods or approach did you use?
We employed a biochemistry-based approach to produce polyglycine proteins in cultured cells and to purify the resultant protein aggregates. Then we used mass spectrometry, which measures the amounts of different molecules in a sample, to comprehensively catalog the set of host cell proteins that are recruited into these aggregates and thereby depleted from cells.
We went on to study the consequences of polyglycine aggregation on RNA processing in cultured cells, confirmed our results in human disease tissues samples, and developed mouse models to functionally assess the consequences of tRNA processing defects in the brain.
Q: What did you find?
We discovered that polyglycine aggregates, both in cultured cells and in human patients, specifically recruit the tRNA ligase complex (tRNA-LC), a group of proteins which is required for processing spliced tRNAs. Notably, mutations in other tRNA splicing genes also cause early-onset neurodegenerative diseases similar to GGC repeat expansion disorders. We found that aggregation of the tRNA-LC leads to misprocessed tRNAs in cultured cells as well as patient brain samples. Moreover, mice in which we depleted the tRNA-LC in the brain developed neurodegeneration and motor coordination deficits similar to those seen in GGC repeat disorders.
Q: What are the implications?
Our work reveals a new and unexpected link between protein aggregation and RNA processing disorders in GGC repeat diseases.
The striking similarities between GGC repeat disorders and previously described tRNA splicing disorders suggests polyglycine-dependent tRNA splicing disruption may be an important mechanism underlying selective neuronal death. Importantly, our findings also establish proof-of-concept that interfering with tRNA-LC aggregation may protect cells from the pathogenic effects of GGC repeat expansions.
Q: What are the next steps?
Our laboratory is now actively working to understand the cellular and molecular consequences in vivo of altered tRNA splicing in the brain. We are very interested in developing therapeutic strategies that can block this pathogenic mechanism in neurodegenerative GGC repeat disorders.
Authorship: In addition to Chivukula, Mass General Brigham authors include Jason Yang, Yunhan Xu, David R. Ziehr, Max L. Valenstein, Jack R. Bush, Kate Rutter, Maheswaran Kesavan, and Ricardo Mouro Pinto.
Paper cited: Yang, J., et al. “Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.” Science. DOI: 10.1126/science.ado2403.
Funding: This work was supported by grants from the Fannie and John Hertz Foundation, the Parker B. Francis Foundation, the National Institute of Diabetes and Digestive and Kidney Diseases (5K08DK129824), the National Institutes of Health (5T32GM007753, R01NS126420), the Medical Research Future Fund, the National Institute of General Medicine Science (5R35GM118135), the Burroughs Welcome Fund, the MGH Department of Surgery Donahoe Catalyst Award, the Chen Institute MGH Department of Medicine Transformative Scholar Award, and the Smith Family Award for Excellence in Biomedical Research.
Disclosures: None
END
Research Spotlight: Study reveals an unexpected role for protein aggregates in brain disease
Researchers from Mass General Brigham release a new study linking protein aggregation to altered RNA processing in genetic forms of neurodegeneration
2025-07-17
ELSE PRESS RELEASES FROM THIS DATE:
UK Government and UK Research and Innovation join forces to launch multi-billion-pound compute roadmap
2025-07-17
Quicker health diagnoses, smarter energy supplies, tackling climate change and improved public service delivery – just some huge potential benefits of the new compute roadmap, launched by DSIT and UKRI.
The roadmap heralds a significant increase in publicly accessible compute capacity. Investments include up to £2 billion to deliver a holistic and user-centred compute ecosystem with £1 billion to expand the AI Research Resource 20-fold by 2030.
It also provides up to £750 million for UKRI to invest in a new national supercomputing service at Edinburgh.
UKRI is further ...
New study in JAMA Network Open shows current approaches to assessing preeclampsia risk are failing the majority of pregnant moms
2025-07-17
South San Francisco, CA (July 17, 2025) - A new study sponsored by Mirvie, which is the first to evaluate U.S. Preventive Services Task Force (USPSTF) guidelines for preeclampsia risk and aspirin prescription in a single, nationally representative, prospective population, found while high-risk factors had sufficient value in estimating risk, there’s limited value for the moderate risk category - leading to nonspecific recommendations for aspirin use, a recognized prevention tool.
This cohort study of 5684 participants, culled from the multi-center Miracle of Life prospective study, found the guidelines ...
An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
2025-07-17
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer.
The study, published in JAMA Network Open in collaboration with researchers at Mayo Clinic in Arizona, found that the absence of detectable tumors after treatment – a key metric in clinical cancer drug trials known as pathologic complete response or pCR – does not reliably predict an improvement in long-term survival for patients diagnosed with ...
Research Spotlight: evaluating the effectiveness of guidelines to predict the risk of preeclampsia
2025-07-17
Q: How would you summarize your study for a lay audience?
Dr. McElrath: Preeclampsia (PE) is a hypertensive disease that complicates 7-10% of pregnancies. While recent advances in understanding the underlying causes of PE have been made, predicting its occurrence has historically been difficult because it is a complex condition that likely results from a variety of causes and can present in different ways.
To address this challenge, the United States Preventive Services Task Force (USPSTF) reviewed ...
Pigment researchers create vivid yellows, oranges, reds that are durable, non-toxic
2025-07-17
CORVALLIS, Ore. – Oregon State University pigment researchers are using a rare mineral discovered in Norway more than a century ago as a road map for creating new yellows, oranges and reds that are vibrant, durable, non-toxic and inexpensive.
The new pigments also carry energy-saving potential: Their ability to reflect heat from the sun means that buildings and vehicles coated in them will require less air conditioning.
The study led by Mas Subramanian, who made color history in 2009 with the discovery of a vivid blue pigment now known commercially as YInMn Blue, was published in Chemistry of Materials.
Funded by the National Science Foundation, ...
Increased transparency about how countries use AI to manage migration needed, new study shows
2025-07-17
Increased transparency from countries about how they use AI to manage migration is needed to boost trust and strengthen the rule of law, a new study says.
Any overuse of AI in migration management may perpetuate biases and errors, promoting excessive reliance on technology and undermining trust in decision‑making processes, an expert has warned. Adequate cybersecurity measures are also needed to protect sensitive data about vulnerable migrants.
However, using AI for migrant management could present opportunities such as freeing up caseworkers’ time to focus on other critical areas, ...
Scientists repurpose old solar panels to convert CO2 exhaust into valuable chemicals
2025-07-17
Centuries ago, alchemists worked furiously to convert the common metal lead to valuable gold. Today, chemists are repurposing discarded solar panels to create valuable organic compounds from carbon dioxide (CO2), a common greenhouse gas.
Significantly reducing greenhouse gasses in the atmosphere to mitigate the most devastating effects of climate change will require a large reduction in emissions as well as strategies designed to sequester emitted CO2 and other offending gasses. While simply sequestering ...
Epidemiology: Key predictors of avian flu outbreaks in Europe identified
2025-07-17
Several local factors — including the minimum temperature reached in autumn, the water level in lakes and ponds in winter, and the presence of mute swans (Cygnus olor) — could be key for predicting the potential of an outbreak of highly pathogenic avian flu (HPAI) occurring in Europe. The findings, published in Scientific Reports, are derived from a machine learning model trained on the characteristics of 21st century European HPAI outbreaks and could help improve future monitoring programmes.
HPAI outbreaks are a serious concern for both animal and public health. A wave of HPAI outbreaks across the Northern Hemisphere during 2022 were associated with an ...
Global rise in many Early-Onset GI cancers detailed in two Dana-Farber reviews, with colorectal cancer leading the trend
2025-07-17
Boston, MA – July 17, 2025 – Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according to two recent literature reviews from Dana-Farber Cancer Institute.
"Early-Onset Gastrointestinal Cancers: A Review," published today in JAMA, provides a comprehensive analysis of the incidence, risk factors, and treatment approaches for early-onset GI cancers. Authors note the rising rate goes ...
Cancer: COVID-19 boosters prevent hospitalizations
2025-07-17
Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators. Their findings, published in JAMA Oncology, offer real-world evidence to support vaccine recommendations for these patients.
“Cancer patients are a vulnerable population,” said Jane Figueiredo, PhD, director of Community Health and Population Research at Cedars-Sinai and senior author of the study. “Their immune systems can be weakened by their disease and the treatments they receive, ...
LAST 30 PRESS RELEASES:
Anna Wuttig wins Bayer Foundation Early Excellence in Science Award
Electric vehicles outperform gasoline cars in lifetime environmental impact
Kilimanjaro has lost 75 percent of its natural plant species over the last century
Spider web “decorations” may help pinpoint location of captured prey
Ancient tombs reveal the story of Chinese history
1 in 3 university students surveyed from a Parisian suburb report being unable to access desired food, with this food insecurity associated with academic dropout
Researchers uncover oldest 3D burrow systems in Hubei's Shibantan Biota
Discovery of a new principle: chiral molecules adhere to magnets
New algorithm lets autonomous drones work together to transport heavy, changing payloads
Lehigh University team develops computational model to guide neurostimulation therapy for atrial fibrillation
Survival of the blandest: Unusual sharks face highest extinction risk
Research alert: Bioinformatics uncovers regenerative therapy for spinal cord injury
Sustainable chemistry with the help of Artificial Intelligence
Quantum jam sessions teach quantum and jamming
Health care professionals sponsored for H-1B visas in the US
Study shows increase of H1-B visa fees will most impact rural and high-poverty counties
How age affects vaccine responses and how to make them better
MAGIC: AI-assisted laser tag illuminates cancer origins
Major milestone achieved in capturing ribosome assembly
International research team decodes the pangenome of oats
A doorstop for the brain’s electrical gates
Tiny 3D printer reconstructs tissues during vocal cord surgery
New genetic marker found to predict severe gout drug reactions in US patients
Schizophrenia, bipolar, or major depressive disorder and postacute sequelae of COVID-19
Fruit flies offer new insights into how human Alzheimer’s Disease risk genes affect the brain
University of Phoenix College of Doctoral Studies releases white paper on mentoring programs to strengthen worker autonomy and competitive edge
International scientists issue State of the Climate Report, highlight mitigation strategies
“State of the climate” 2025: Earth’s vital signs worsen, science shows options for livable future
New nanomedicine wipes out leukemia in animal study
National TRAP Program targets ghostly issue with second round of coastal clean up funding
[Press-News.org] Research Spotlight: Study reveals an unexpected role for protein aggregates in brain diseaseResearchers from Mass General Brigham release a new study linking protein aggregation to altered RNA processing in genetic forms of neurodegeneration